Biogen Inc.

United States, Massachusetts, Cambridge

Report a bug?

Claim ownership and edit

Updated Jul 18, 2024 10:31

Description

Biogen is a global biopharmaceutical company focused on discovering, developing and delivering innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Biogen's marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy (SMA); SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS; and FUMADERM for the treatment of severe plaque psoriasis. Biogen, which serves customers around the world, gets majority of its revenue from the US.

Industries

Pharmaceutical and Medicine Manufacturing; Scientific Research and Development Services; Chemical Manufacturing; Manufacturing

SIC

Pharmaceutical Preparations; Commercial Physical Research; Chemicals and Allied Products; Manufacturing

Address:

225 Binney St Cambridge

02142-1031 United States

Website:

www.biogen.com:443

Revenue

$9840M

Company is likely to buy

Company is likely to sell

Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.